abstract |
The present invention relates to novel pharmaceutically acceptable salts of 2-hydroxy-3- [5- (morpholin-4-ylmethyl) pyridin-2-yl] 1H-indole-5-carbonitrile, processes for their preparation, It relates to pharmaceutical formulations containing such salts and to the use of said active salts in therapy and in particular to GSK3-related disorders. |